Rajen Desai, MD
Ophthalmology · Freehold, NJNPI 1174788699
Payments from drug & device makers
Across 714 payments — averaging $454.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$130K
- AbbVie$66K
- Glaukos Corporation$48K
- Rayner Intraocular Lenses Limited$21K
- NEW World Medical,inc.$10K
- Beaver-visitec International, Inc.$10K
- plus $38K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 146 | $130,369 |
| AbbVie(2 entities) | 174 | $66,283 |
| Glaukos Corporation | 55 | $48,481 |
| Rayner Intraocular Lenses Limited | 17 | $21,077 |
| NEW World Medical,inc. | 27 | $10,270 |
| Beaver-visitec International, Inc. | 6 | $9,525 |
| Sight Sciences, Inc. | 34 | $9,484 |
| Alcon | 26 | $6,211 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 31 | $6,010 |
| Sun Pharmaceutical Industries Inc. | 52 | $5,140 |
| Ocular Therapeutix, Inc. | 11 | $4,073 |
| Ivantis, Inc | 4 | $2,632 |
| Iridex Corporation | 9 | $1,793 |
| Johnson & Johnson Surgical Vision, Inc. | 31 | $1,257 |
| Microsurgical Technology, Inc. | 2 | $382 |
| Novartis | 35 | $345 |
| Biotissue Holdings Inc. | 16 | $266 |
| Mallinckrodt Hospital Products Inc. | 4 | $136 |
| Kala Pharmaceuticals, Inc. | 9 | $132 |
| Eyepoint US, Inc. | 6 | $84 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $73 |
| Tarsus Pharmaceuticals, Inc. | 4 | $67 |
| Oyster Point Pharma, Inc. | 4 | $67 |
| Nova Eye, Inc. | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
| Aerie Pharmaceuticals, Inc. | 2 | $28 |
| Shire North American Group Inc | 2 | $24 |
| Amgen | 1 | $18 |
| Harrow Eye, LLC | 1 | $17 |
How this compares
$324,310 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Freehold
- Alain BauzaFreehold$58K
- Eric GershenbaumFreehold$23K
- Revathi NaadimuthuFreehold$12K
- Patrick HigginsBloomfield$16.7M
- Jai ParekhWoodland Park$2.1M
- Eric MannDover$860K
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Luis Gonzalez GonzalezTeaneck$727K
- Cynthia MatossianPennington$726K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.